Suppr超能文献

默克尔细胞癌患者总生存期和癌症特异性生存期的列线图预测

Nomogram prediction for the overall survival and cancer-specific survival of patients diagnosed with Merkel cell carcinoma.

作者信息

Yin Xufeng, She Huihui, Martin Kasyanju Carrero Lorna, Ma Weiwei, Zhou Bingrong

机构信息

Department of Dermatology, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China.

出版信息

Ann Transl Med. 2021 Feb;9(4):286. doi: 10.21037/atm-20-4578.

Abstract

BACKGROUND

Merkel cell carcinoma (MCC) is a rare and aggressive neuroendocrine carcinoma of the skin, with a high recurrence rate and a high mortality rate worldwide. The purpose of this article is to construct a nomogram that incorporates significant clinical parameters and predicts the survival of individuals with MCC.

METHODS

The Surveillance, Epidemiology, and End Results (SEER) database was employed to retrospectively analyze all confirmed MCC cases from 2004 to 2015. The data was collected from 3,688 patients, and was randomized as the training or validation group (1:1 ratio). The independent factors which predicted the cancer-specific survival (CSS) and overall survival (OS) for MCC cases were searched for nomogram construction respectively. Independent parameters that affected CSS were determined using the Fine and Gray competing risk regression model. In addition, the time-dependent receiver operating characteristic (ROC) curve was constructed. Then, the area under the curve (AUC) values, calibration curve, and the concordance index (C-index) were used to determine the nomogram performance. At last, decision curve analysis (DCA) was conducted to determine the net clinical benefit.

RESULTS

The multivariate analysis results revealed that sex, age, race, marriage, American Joint Committee on Cancer (AJCC) stage, chemotherapy and radiotherapy were independent OS prognostic factors. Furthermore, competing risk analysis showed age, sex, AJCC stage, chemotherapy were the independent CSS prognostic factors. For validation, the C-index value of OS nomogram was 0.703 (95% CI: 0.686-0.721), while C-index value of CSS nomogram was 0.737 (95% CI: 0.710-0.764). Both C-index and AUC suggested that nomograms had superior performance to that of the AJCC stage system. In addition, according to the calibration curve, both nomograms were capable of accurate prediction of MCC prognosis. The DCA showed that the net benefits of the nomograms were superior among various threshold probabilities than these of AJCC stage system.

CONCLUSIONS

The present work established and verified the novel nomograms to predict the OS and CSS of MCC patients. If further confirmed in future studies, it may become another helpful tool for risk stratification and management of MCC patients.

摘要

背景

默克尔细胞癌(MCC)是一种罕见的侵袭性皮肤神经内分泌癌,在全球范围内复发率和死亡率都很高。本文的目的是构建一个纳入重要临床参数的列线图,以预测MCC患者的生存情况。

方法

利用监测、流行病学和最终结果(SEER)数据库对2004年至2015年所有确诊的MCC病例进行回顾性分析。数据收集自3688例患者,并随机分为训练组或验证组(1:1比例)。分别寻找预测MCC病例癌症特异性生存(CSS)和总生存(OS)的独立因素用于构建列线图。使用Fine和Gray竞争风险回归模型确定影响CSS的独立参数。此外,构建时间依赖性受试者操作特征(ROC)曲线。然后,使用曲线下面积(AUC)值、校准曲线和一致性指数(C指数)来确定列线图的性能。最后,进行决策曲线分析(DCA)以确定净临床获益。

结果

多因素分析结果显示,性别、年龄、种族、婚姻状况、美国癌症联合委员会(AJCC)分期、化疗和放疗是独立的OS预后因素。此外,竞争风险分析表明年龄、性别、AJCC分期、化疗是独立的CSS预后因素。用于验证时,OS列线图的C指数值为0.703(95%CI:0.686 - 0.721),而CSS列线图的C指数值为0.737(95%CI:0.710 - 0.764)。C指数和AUC均表明列线图的性能优于AJCC分期系统。此外,根据校准曲线,两个列线图都能够准确预测MCC的预后。DCA显示,在各种阈值概率下,列线图的净获益优于AJCC分期系统。

结论

本研究建立并验证了用于预测MCC患者OS和CSS的新型列线图。如果在未来研究中得到进一步证实,它可能成为MCC患者风险分层和管理的另一个有用工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6350/7944317/27c8a303f341/atm-09-04-286-f1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验